BioInsights - New horizons in cellular immunotherapy: next-gen platforms and modalities - spotlight

CELL & GENE THERAPY INSIGHTS

New horizons in cellular immunotherapy: next-gen platforms and modalities

David Morrow
Guest Editor:
David Morrow, Scientific Programme Manager, Translational Medicine & Drug Development at EATRIS
October 2020

New horizons in cellular immunotherapy: next-gen platforms and modalities
Download PDF

Expert Insight


Innovator Insight


Commentary


Interview


Regulatory Insight


Webinars